Kevin McKernan Leaves Life Technologies on a High.

The article focuses on life scientist Kevin McKernan and his start-up, Medicinal Genomics. It notes that after the departure of McKernan from Life Technologies, his start-up is attracting attention for its sequencing project involving the cannabis genome. McKernan states that he left his former company as he began to be serious about the anti-cancer properties of cannabinoids. Another goal of the start-up involves the incubation of assembly algorithms with a hyper-focus on different organisms.